Angioimmunoblastic T-cell lymphoma is a rare and aggressive form of non-Hodgkin lymphoma characterized by the proliferation of abnormal T-cells. It often presents with systemic symptoms such as fever, weight loss, and lymphadenopathy. Accurate coding with ICD-10 Code C86.5 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this complex condition.
ICD-10 Code C86.5 specifically identifies Angioimmunoblastic T-cell lymphoma, a subtype of peripheral T-cell lymphoma. This code should be used when documenting cases of this malignancy, which is associated with immune dysregulation and can lead to significant morbidity. Proper use of this code in clinical documentation and billing is crucial for accurate patient care and reimbursement.
Angioimmunoblastic T-cell lymphoma is a hematological malignancy that arises from the proliferation of activated T-cells, often linked to viral infections and autoimmune diseases. It typically progresses rapidly and requires prompt medical intervention to manage symptoms and prevent complications.
ICD-10 Code C86.5 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of Angioimmunoblastic T-cell lymphoma. This code aids in capturing the patient's symptoms, guiding clinical decision-making, and ensuring appropriate billing in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C86.5 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Angioimmunoblastic T-cell lymphoma. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Angioimmunoblastic T-cell lymphoma often necessitates hospitalization for intensive treatment. Chemotherapy is the primary treatment modality, and supportive care is crucial for managing symptoms.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C86.5 is critical for billing in hospital, ER, or infectious disease care settings, ensuring accurate reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance/drug |
| 99223 | Initial hospital care, typically 70 minutes or more, for the evaluation and management of a patient |
| 85025 | Complete blood count (CBC) with automated differential white blood cell count |
| 36415 | Collection of venous blood by venipuncture |
Common Questions About Using ICD-10 Code C86.5 for Angioimmunoblastic T-cell lymphoma
What are the common symptoms of Angioimmunoblastic T-cell lymphoma?
Common symptoms include fever, night sweats, weight loss, lymphadenopathy, and skin rashes. Patients may also experience fatigue and generalized weakness.
How is Angioimmunoblastic T-cell lymphoma diagnosed?
Diagnosis typically involves a combination of clinical evaluation, imaging studies, and biopsy of affected lymph nodes to confirm the presence of abnormal T-cells.
What treatments are available for Angioimmunoblastic T-cell lymphoma?
Treatment usually includes chemotherapy, and in some cases, stem cell transplantation may be considered. Supportive care is also essential to manage symptoms.
How does ICD-10 Code C86.5 impact billing?
Using ICD-10 Code C86.5 ensures accurate billing for services related to Angioimmunoblastic T-cell lymphoma, facilitating appropriate reimbursement and compliance with coding standards.
Clinical Notes
SOAP notes
DAP notes
AI medical notes